Switch View
© BusinessWire
30.09.2025
ISIN: US67080N1019
Nuvation Bio Inc
NUVB
LISTED
NYSE
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it has enrolled the first patient in TRUST-IV (NCT07154706), a Phase 3 study evaluating the efficacy and safety of IBTROZI™ (taletrectinib), a next-generation ROS1 inhibitor, versus placebo for the adju...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
News Preview
Vote clears final corporate milestone, paving the way for the closing of the merger and the combined company of NewCelX Ltd., a Nasdaq-listed biotechnology company
ZURICH, Sept. 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US5049221055
Labcorp Holdings Inc
LH
LISTED
NYSE
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities
News Preview
Labcorp to leverage Roche's digital pathology technology to expand access, enhance efficiency and support AI integration across anatomic pathology services
BURLINGTON, N.C., Sept. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and com...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
30.09.2025
ISIN: DK0060448595
Coloplast A/S
COLO B
LISTED
CPH
Coloplast A/S - Financial Calendar 2025-26
News Preview
Please see enclosed pdf....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
30.09.2025
ISIN: US2546041011
Disc Medicine Inc
IRON
LISTED
NASDAQ
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
News Preview
WATERTOWN, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the submission of a New Drug Application (NDA) to the U.S. Foo...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US7743743004
Rockwell Medical Inc
RMTI
LISTED
NASDAQ
Rockwell Medical Promotes Heather Hunter to Chief Operating Officer
News Preview
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Heather Hunter was promoted to Chief Operating Officer, and will continue to report to the Company's President and CEO, D...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US52635N1037
LENZ Therapeutics Inc
LENZ
LISTED
NASDAQ
LENZ Therapeutics Announces Commercial Product Availability of VIZZ™ in the United States
News Preview
VIZZ sample distribution initiated nationwide to Eye Care Professionals...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US53216B1044
LifeMD, Inc.
LFMD
LISTED
NASDAQ
LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk
News Preview
Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US91864C1071
Vaccitech plc
VACC
LISTED
NASDAQ
Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases
News Preview
GERMANTOWN, Md. and ALTRINCHAM, United Kingdom, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”), an immunology and inflammation company focused on developing therapies that promote immune tolerance, and Clywedog Therapeutics, Inc. (“Clywedog”), a private company advancing novel breakthrough medici...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: JP3546800008
Terumo Corporation
45430
LISTED
XJPX
Kenya, Uganda and Côte d'Ivoire Partner with Terumo Blood and Cell Technologies to Build Coordinated National Care Frameworks for Sickle Cell Care
News Preview
LAKEWOOD, Colo., Sept. 30, 2025 /PRNewswire/ -- In a landmark move, the Ministries of Health of Kenya and Côte d'Ivoire, together with Uganda's Joint Clinical Research Centre (JCRC) under the stewardship of the Uganda Ministry of Health, have signed three Memoranda of Understanding (MoUs) with Terumo Blood and Ce...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2025
ISIN: DE000A3MQR65
Viromed Medical AG
Q11
LISTED
XETRA
Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs
News Preview
PRESS RELEASE
Viromed Medical AG launches in vivo and ex vivo study with cold plasma on living lungs
Rellingen, September 30, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, announces the start of a comprehensive in vivo and ex vivo study on living lungs. The in vivo a......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2025
ISIN: DE000A3MQR65
Viromed Medical AG
Q11
LISTED
XETRA
Viromed Medical AG startet In-vivo- und Ex-vivo-Studie mit Kaltplasma an lebenden Lungen
News Preview
PRESSEMITTEILUNG
Viromed Medical AG startet In-vivo- und Ex-vivo-Studie mit Kaltplasma an lebenden Lungen
Rellingen, 30. September 2025 – Die Viromed Medical AG („Viromed“; ISIN: DE000A3MQR65), ein Medizintechnikunternehmen und Pionier der Kaltplasmatechnologie, gibt den Start einer umfangreichen In-vivo- und Ex-vivo-Studie an lebenden Lungen bek......
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
30.09.2025
ISIN: US67576A1007
Ocular Therapeutix Inc
OCUL
LISTED
NASDAQ
Ocular Therapeutix™ Announces Pricing of Underwritten Offering of Common Stock
News Preview
BEDFORD, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (Nasdaq: OCUL) (“Ocular”, the “Company”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced the pricing of an underwritten offering of 37,909,018 shares of its common stock at an offering price of $12.53 per share for g...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings
News Preview
NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today anno...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: CA39342L1085
Green Thumb Industries Inc
GTII
LISTED
CSE
Green Thumb Expands Pennsylvania Retail Footprint with RISE Dispensary Lebanon
News Preview
CHICAGO and VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced its latest Pennsylvania location, RISE Dispensary Lebanon. Located at 1600 W Cumberland St. conveni...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US00461U1051
Aclaris Therapeutics Inc
ACRS
LISTED
NASDAQ
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025
News Preview
Aclaris Therapeutics to Host In-Person and Webcast R&D Day in New York on October 14, 2025...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.09.2025
ISIN: AU000000CUV3
Clinuvel Pharmaceuticals Ltd
CUV
LISTED
ASX
Parmantier & Cie. GmbH: CLINUVEL Pharmaceuticals Limited | Rating: Buy
News Preview
Original-Research: CLINUVEL Pharmaceuticals Limited - from Parmantier & Cie. GmbH
30.09.2025 / 10:52 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this research. The result of this research does not constitute investment advice or an invitation to c......
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion’s phase 2 study of ODM-105 in insomnia did not meet primary goal
News Preview
ORION CORPORATION PRESS RELEASE 30 SEPTEMBER 2025 at 13.00 EEST ...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
WINREVAIR™ (sotatercept-csrk) Reduced the Risk of Clinical Worsening Events by 76% Compared to Placebo in Patients Recently Diagnosed With PAH on Background Therapy in Phase 3 HYPERION Trial
News Preview
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from the Phase 3 HYPERION trial evaluating WINREVAIR™ (sotatercept-csrk) versus placebo (both in combination with background therapy) in recently diagnosed adults with pulmonary arterial hypertension (PAH, WHO* Group 1) functional class (FC) II o...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / September 30, 2025 / Lunai Bioworks Inc. (Nasdaq:LNAI), a pioneer in AI-powered drug discovery and biodefense, today announced the formal adoption of its new corporate identity, reflecting a sharpened strategic focus and a streamlined capital structure following a 10:1 reverse stock split.The rebranding f...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease
News Preview
The two programs are being conducted under separate Single-Patient Investigational New Drug (sIND) applications in the United States SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family company Napo Pharmaceuticals (Napo) is providing the company's novel crofelemer powder for oral...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US6300872032
NanoViricides, Inc.
NNVC
LISTED
XASE
NanoViricides, Inc. Has Filed its Annual Report
News Preview
Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that it has filed its Annual Report on Form 10-K for the fiscal ye...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
New number of shares and votes in Sobi
News Preview
STOCKHOLM, Sept. 30, 2025 /PRNewswire/ -- As per 30 September 2025, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 357,412,837 shares. All shares are common shares. The total number of votes is 357,412,837. The increase in the number of common shares and votes, and the decreas...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: SE0000872095
Swedish Orphan Biovitrum AB (publ)
SOBI
LISTED
STO
New number of shares and votes in Sobi
News Preview
STOCKHOLM, Sept. 30, 2025 /PRNewswire/ -- As per 30 September 2025, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi®) amounts to 357,412,837 shares. All shares are common shares. The total number of votes is 357,412,837. The increase in the number of common shares and votes, and the decreas...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: US91678A1079
Upstream Bio, Inc.
UPB
LISTED
NASDAQ
Upstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society Congress
News Preview
– Data show verekitug prevents TSLP binding to the TSLP receptor by occupying ligand binding sites –...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
News Preview
The Balancing Act airing on Lifetime will showcase how innovative treatments Thermage® FLX, Clear + Brilliant®, and Fraxel FTX™ offer energy-based treatment options that help maintain a youthful appearance while enhancing natural beauty. LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:B...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US9495031067
Wellgistics Health, Inc.
WGRX
LISTED
NASDAQ
Wellgistics Health (NASDAQ:WGRX) and TheracosBio Partner to Expand Nationwide, PBM-Free Access to Brenzavvy(R), an FDA-Approved Diabetes Therapy, Through 6,500+ Pharmacies
News Preview
TAMPA, FL / ACCESS Newswire / September 30, 2025 / Wellgistics Health, Inc. ("Wellgistics Health" or the "Company") (NASDAQ:WGRX), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced a strategic collaboration with TheracosBio, the manufacturer of...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US60458C1045
Mira Pharmaceuticals Inc
MIRA
LISTED
NASDAQ
MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction
News Preview
Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs including Ketamir-2 and MIRA-55 MIAMI, FLORIDA / ACCESS Newswire / September 30, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US12482V1035
CBD Life Sciences Inc.
CBDL
LISTED
OTC
CBD Life Sciences Inc. (CBDL) Secures Landmark Agreement with Bronx Powerhouse Dispensary Smoking Scholars
News Preview
With New York dispensaries projected to surpass $4.4 billion in annual sales by 2027, CBDL secures a transformative partnership poised to generate multi-million-dollar revenues and accelerate nationwide expansion. SCOTTSDALE, AZ / ACCESS Newswire / September 30, 2025 / CBD Life Sciences Inc. (OTC:CBDL), through its operating subsidiary CBD Vault, t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health to Announce Third Quarter 2025 Results on October 29
News Preview
LAVAL, QC / ACCESS Newswire / September 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release third quarter 2025 financial results after market close on Wednesday, October 29, 2025. Bausch Health will host a live conference call and webcast at 5:00 p.m. U.S. EDT to discuss results and provide a business update. All materials will...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: CA00143Y1034
AI-ML Innovations Inc.
AIML
LISTED
CSE
AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection
News Preview
Leveraging MaxYield™ ECG to capture real-world exercise data in people living with neurological conditionsGenerating actionable insights into how cardiac responses may correlate with brain health and outcomes TORONTO, ON / ACCESS Newswire / September 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OT...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: FI0009014377
Orion Oyj
ORNBV
LISTED
HEL
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
News Preview
ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS30 September 2025 at 9.00 EEST ...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks
News Preview
Basel, 30 September 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the primary results from the TSIX Study Program, which evaluated the performance of its new sixth-generation high-sensitivity Troponin T test for diagnosing heart attacks. Presented at the European Society for Emergency Medicine (EUSEM) 20252 and the European Society of Cardiol...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: CH0029850754
Addex Therapeutics Ltd
ADXN
LISTED
SIX
Addex Therapeutics Reports 2025 Half Year and Second Quarter Financial Results and Provides Corporate Update
News Preview
Ad Hoc Announcement Pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.09.2025
ISIN: CH0325814116
Kuros Biosciences AG
KURN
LISTED
SIX
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025
News Preview
Kuros Biosciences debuts commercial launch of MagnetOs MIS Delivery System at SMISS 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf o...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: FR0014000MR3
Eurofins Scientific SE
ERF
LISTED
EURONEXT
Microplastics in the Air: Global Study Uncovers Concerning Levels of Daily Exposure
News Preview
The PlasticDustCloud project, a global study led by the Eurofins Environment Testing network, has revealed alarming microplastic pollution in air, with deposition rates of up to 1,300 microplastics per square metre per day (/m2/day). Working with samples collected across 12 sites in 9 countries on 3 continents, this global study highlights the per...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: CA05156V1022
Aurinia Pharmaceuticals Inc
AUPH
LISTED
NASDAQ
Aurinia Responds to Now Retracted LinkedIn Post
News Preview
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today responded to a now retracted LinkedIn post referencing voclosporin by an FDA official.
Aurinia stands behind the favorable benefit/risk profile of LUPKYNIS® (voclosporin). LUPKYNIS received full approval from the FDA in January 2021 based on a large, randomized 52-week clinical study known as AUR...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US0905722072
Bio Rad Laboratories, Inc.
BIO
LISTED
NYSE
Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away
News Preview
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Alice N. Schwartz, Bio-Rad’s co-founder and Director Emeritus, passed away on September 25, 2025, at the age of 99.
Mrs. Schwartz co-founded Bio-Rad in 1952 in Berkeley, California, together with her...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: GB00BYX3WZ24
Hemogenyx Pharmaceuticals plc
HEMO
LISTED
LSE
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
News Preview
Interim Results for the period ended 30 June 2025 LONDON, UK / ACCESS Newswire / September 30, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing therapies designed to transform blood disease treatment, whose Shares are admitted to the equity shares (transition) category of the Official List, announces its unaud...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: GB00BP2C3V08
Genflow Biosciences Plc
GENF
LISTED
LSE
Genflow Biosciences PLC Announces Half-Year Report
News Preview
LONDON, UNITED KINGDOM / ACCESS Newswire / September 30, 2025 / Genflow (LSE:GENF)(OTCQB:GENFF) is pleased to announce its half year results for the six-month period ended 30 June 2025.Chairman's StatementIt is my pleasure to update shareholders of Genflow Biosciences Plc ("Genflow" or the "Company") on our performance during th...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US81684M1045
Semler Scientific Inc
SMLR
LISTED
NASDAQ
SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the "Class Period"), of the important October 28, 2025 lead plaintiff deadlin...
Themefolio
Profiler
Peergroup
© BusinessWire
30.09.2025
ISIN: US0162551016
Align Technology, Inc.
ALGN
LISTED
NASDAQ
Align Technology Advances Digital Orthodontics With Invisalign® Through Best-in-Class Clinical Education and Peer-to-Peer Learning at Its Global Faculty Meeting of Doctor Educators
News Preview
Align Technology, Inc. (NASDAQ: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today shared highlights from its 2025 Global Faculty Meeting, reinforcing its commi...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Investors: November 10, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
News Preview
RADNOR, Pa., Sept. 29, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus secu...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: JP3431300007
Nxera Pharma Co Ltd
45650
LISTED
XJPX
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
News Preview
Tokyo, Japan and Cambridge and London, UK, 30 September 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that it has reached a second important R&D milestone under its multi-target discovery collaboration with AbbVie focused on neurological diseases, resulting in a payment of US$10 million to Nxera....
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purc...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: JE00BYSS4X48
Novocure Ltd
NVCR
LISTED
NASDAQ
Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting
News Preview
Novocure (NASDAQ: NVCR) announced that final results from the Phase 3 METIS trial of Tumor Treating Fields (TTFields) therapy for brain metastases from non-small cell lung cancer (NSCLC) will be presented today at the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting taking place September 27 – October 1 in San Francisco and simu...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: CA25253X2077
DiaMedica Therapeutics, Inc.
DMAC
LISTED
NASDAQ
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
News Preview
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that on September 18, 2025, it granted stock options to purchase an aggregate of 490,000 shares of DiaMedica’s common stock to five newly...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
SVRA Investors have Opportunity to Lead Savara Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Savara Inc. (NASDAQ: SVRA) b...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US0345691036
Anebulo Pharmaceuticals, Inc.
ANEB
LISTED
NASDAQ
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Recent Updates
News Preview
Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced financial results for the three and twelve months ended June 30, 2025, and recent updates.
Fourth Quarter Fiscal Year 2025 an...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: CA00288U1066
Abcellera Biologics Inc
ABCL
LISTED
NASDAQ
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
News Preview
AbCellera (Nasdaq: ABCL) will announce its third quarter 2025 financial results on Thursday, November 6, 2025, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.
A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations w...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division
News Preview
The Consumer Health division of Bayer has selected Interpublic Group (NYSE: IPG) as the global agency partner for all creative, production and media, responsible for marketing activities for some of the most trusted and well-known brands in self-care.
The selection of an integrated agency across brands and regions represents a new era in how Bay...
Themefolio
Profiler
Peergroup
© BusinessWire
29.09.2025
ISIN: US03815U6073
Applied DNA Sciences, Inc.
BNBX
LISTED
NASDAQ
Applied DNA Sciences Announces Private Placement of Up To $58 Million To Initiate BNB Treasury Strategy and BNB Native Yield Generation
News Preview
Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a biotechnology company focused on providing nucleic acid production solutions, today announced up to $58 million in commitments for a private investment in public equity (“PIPE”) offering led by institutional investors to initiate a digital asset treasury strategy based o...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US8693671021
Sutro Biopharma Inc
STRO
LISTED
NASDAQ
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
News Preview
– Extends cash runway into at least mid-2027 –...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US67079U3068
Nutex Health Inc
NUTX
LISTED
NASDAQ
NUTX Investors Have Opportunity to Lead Nutex Health Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ:...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US02155H1014
Altimmune, Inc.
ALT
LISTED
NASDAQ
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between August 10, 2023 and June 25, 2025, both dates inclusive (the "Class Period"), of the important October 6, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: IE000LK2BOB4
Mural Oncology PLC
MURA
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PHLT, ARIS, MURA on Behalf of Shareholders
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
Themefolio
Profiler
Peergroup
© PR Newswire
29.09.2025
ISIN: US2825591033
89Bio, Inc.
ETNB
LISTED
NASDAQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PINC, MTSR, ETNB on Behalf of Shareholders
News Preview
NEW YORK, Sept. 29, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US7402944000
Precision Optics Corp, Inc.
POCI
LISTED
NASDAQ
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
News Preview
Conference Call Scheduled for today, September 29, 2025, at 5:00pm ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.09.2025
ISIN: US5526411021
MAIA Biotechnology Inc
MAIA
LISTED
XASE
MAIA Biotechnology Announces $2.25 Million Private Placement
News Preview
CHICAGO, IL, Sept. 29, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,733,766 shares of common s...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
